Igene Biotechnology, Inc.
Igene Biotechnology, Inc.
Your view on IGNE
Overview
What the company does, where it operates, and who runs it.
About Igene Biotechnology, Inc.
- Industry
- Agricultural Inputs
- Sector
- Basic Materials
- CEO
- Joseph L. Downs
- Headquarters
- 9110 Red Branch Road, Columbia, MD, US
- Industry
- Agricultural Inputs
- Sector
- Basic Materials
- CEO
- Joseph L. Downs
- Headquarters
- 9110 Red Branch Road, Columbia, MD, US
Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species.
It also supplies ingredients and finished products to the nutraceutical and feed industry.
The company also provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors; and analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids.
The company was formerly known as IGI Biotechnology, Inc. and changed its name to IGENE Biotechnology, Inc. in April 1986. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Igene Biotechnology, Inc., and the rating behind it. IGNE last traded at $0.0000; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Igene Biotechnology, Inc.. Starting points for Igene Biotechnology, Inc.: beta -23.34 — an Agricultural Inputs name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Igene Biotechnology, Inc.. Igene Biotechnology, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Igene Biotechnology, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Igene Biotechnology, Inc.. Igene Biotechnology, Inc. has reported as a listed company since 1995. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Igene Biotechnology, Inc. valued side by side against its closest peers. Igene Biotechnology, Inc. is measured against Agricultural Inputs peers within the Basic Materials sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Igene Biotechnology, Inc., and how their positions are changing. At a $15,654 market value, institutional positions materially move Igene Biotechnology, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Igene Biotechnology, Inc. executives and directors. Shares of Igene Biotechnology, Inc. have traded between $0.0000 and $0.0000 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Igene Biotechnology, Inc.. Igene Biotechnology, Inc. is a $15,654 Basic Materials company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Igene Biotechnology, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Igene Biotechnology, Inc.. Coverage tracks Igene Biotechnology, Inc. within Agricultural Inputs (Basic Materials). Press releases and market coverage, newest first.